IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.131
EU - Europa 2.602
AS - Asia 1.894
SA - Sud America 348
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 8.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.090
SG - Singapore 880
IT - Italia 552
UA - Ucraina 395
IE - Irlanda 393
CN - Cina 307
BR - Brasile 295
SE - Svezia 294
HK - Hong Kong 273
VN - Vietnam 227
DE - Germania 208
RU - Federazione Russa 190
FI - Finlandia 135
RO - Romania 112
FR - Francia 99
GB - Regno Unito 75
KR - Corea 58
IN - India 37
CZ - Repubblica Ceca 33
AR - Argentina 27
BE - Belgio 25
PL - Polonia 22
TR - Turchia 21
CA - Canada 19
CH - Svizzera 18
CI - Costa d'Avorio 15
BD - Bangladesh 14
UZ - Uzbekistan 14
MX - Messico 13
NL - Olanda 12
AT - Austria 11
GR - Grecia 11
EC - Ecuador 10
JP - Giappone 10
ES - Italia 8
LB - Libano 8
MA - Marocco 8
PK - Pakistan 8
IQ - Iraq 7
ZA - Sudafrica 6
CO - Colombia 5
IL - Israele 5
PE - Perù 5
EU - Europa 4
ID - Indonesia 4
LT - Lituania 4
JO - Giordania 3
NG - Nigeria 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
EG - Egitto 2
KE - Kenya 2
LC - Santa Lucia 2
PH - Filippine 2
PS - Palestinian Territory 2
VE - Venezuela 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 8.022
Salva come PNG Salva come JPEG
Città #
Singapore 594
Chandler 427
Dublin 393
Perugia 326
Hong Kong 273
San Mateo 232
Jacksonville 191
Boardman 157
Dong Ket 135
Ashburn 120
Santa Clara 119
Bucharest 111
Wilmington 97
Medford 94
Princeton 93
Beijing 90
Altamura 89
Redmond 89
Munich 82
Ann Arbor 77
Andover 70
Des Moines 69
Lawrence 68
Seoul 57
Moscow 52
New York 47
Los Angeles 46
Falls Church 45
Ho Chi Minh City 36
Dearborn 34
Turku 32
São Paulo 29
Woodbridge 28
Pisa 26
Saint Petersburg 26
Brussels 25
Norwalk 22
Piscataway 20
Chennai 19
Dallas 19
Brno 18
The Dalles 17
Warsaw 17
Boston 16
Fremont 16
Hanoi 16
Helsinki 16
Abidjan 15
Brooklyn 15
Nuremberg 15
Chicago 14
San Paolo di Civitate 14
Olomouc 13
Poplar 13
Orem 12
Denver 11
Milan 11
Atlanta 10
Guangzhou 10
Izmir 10
London 9
San Diego 9
Seattle 9
Shanghai 9
Tokyo 9
Belo Horizonte 8
Phoenix 8
San Francisco 8
San Jose 8
Ankara 6
Columbus 6
Den Haag 6
Fortaleza 6
Frankfurt am Main 6
Hanover 6
Houston 6
Jinan 6
Montreal 6
Nanjing 6
Stockholm 6
Tianjin 6
Chengdu 5
Paris 5
Redwood City 5
Tashkent 5
Athens 4
Bauru 4
Brasília 4
Curitiba 4
Goiânia 4
Guayaquil 4
Haiphong 4
Johannesburg 4
Joinville 4
Mumbai 4
Nagpur 4
Secaucus 4
Tappahannock 4
Wuhan 4
Auburn Hills 3
Totale 5.066
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 191
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 180
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 176
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 166
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 165
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 160
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 155
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 154
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 138
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 134
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 131
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 130
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 128
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 120
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 118
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 117
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 115
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 114
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 113
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 112
The TGF-β/IDO axis in infectious tolerance. 110
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 109
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 106
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 104
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 104
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 103
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 103
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 100
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 99
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 96
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 96
Modulation of tryptophan catabolism by regulatory T cells 93
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 93
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 92
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 92
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 91
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 89
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 88
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 87
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 87
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 84
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 83
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 83
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 81
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 81
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 80
T cell apoptosis by tryptophan catabolism 80
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 80
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 79
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 79
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 79
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 78
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 77
CTLA-4-Ig regulates tryptophan catabolism in vivo. 76
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 75
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 75
Immunomodulatory properties of ribavirin in the mouse. 74
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 73
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 73
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 73
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 73
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 71
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 71
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 71
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 70
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 69
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 69
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 69
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 68
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 68
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 68
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 66
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 66
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 65
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 65
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 62
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 58
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 56
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 55
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 54
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 53
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 53
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 50
Molecular and genomic aspects of xenogenizing-alkylating drugs. 49
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 48
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 48
Tryptophan catabolism in nonobese diabetic mice. 48
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 43
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 42
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 41
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 39
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 32
Totale 8.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021536 0 0 0 0 0 68 93 5 109 41 69 151
2021/20221.141 15 160 12 52 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/20251.340 23 113 98 72 160 62 47 88 231 85 208 153
2025/20261.676 189 240 161 421 365 300 0 0 0 0 0 0
Totale 8.280